3.990USD0.00%Mkt Cap: 163.70M USDP/E: 1.54Last update: 2026-05-26
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, wh…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap163.70M USD
Enterprise Value114.18M USD
Revenue (TTM)0 USD
Gross Profit13.00K USD
Net Income (TTM)64.05M USD
Revenue/Share0.0000 USD
Last Price3.990 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS68403P2039
Valuation
P/E (Trailing)1.54
P/E (Forward)-54.75
PEG—
EV/EBITDA-8.08
EV/Revenue—
P/SInfinity
P/B0.86
EPS (TTM)2.60
EPS (Forward)-0.08
52W Range
1.98066% of range5.010
52W High5.010 USD
52W Low1.980 USD
Profitability
Gross Margin0.65%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin3202.50%
ROE32.07%
ROA27.74%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.14M USD
CapEx (TTM)1.93M USD
FCF Margin—
FCF Yield0.43%
Net Debt-65.08M USD
Net Debt/EBITDA4.61
Balance Sheet
Debt/Equity0.00
Current Ratio6.45
Quick Ratio6.23
Book Value/Sh5.086 USD
Cash/Share1.609 USD
Dividends
Fwd Div Rate0.2500 USD
Trail. Div Rate0.0000 USD
Div. Yield5.71%
5Y Avg Yield—
Payout Ratio9.62%
Ex-Div DateJan 16, 2026
Pay DateJan 26, 2026
Splits
Last Split1:12
Split DateJan 23, 2013
Analyst Consensus
Rating—
Target (Mean)6.250 USD
Target Range6.250 USD – 6.250 USD
# Analysts1
Ownership
Shares Out.40.45M
Float28.43M
Insiders17.83%
Institutions37.08%
Short Interest
Short Ratio5.4d
Short % Float1.91%
Short % Out.1.61%
Shares Short650.65K
Short (prev mo.)562.98K
Technical
SMA 503.821 (+4.4%)
SMA 2003.013 (+32.4%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)178.71K
Avg Vol (10d)239.65K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—